Ashleigh Palmer, President & CEO at UNIGENE LABORATORIES INC (UGNE), bought 8,800 shares at $0.70 ($6K) on 2010-09-20, disclosed to the SEC on 2010-09-21.
Open-market purchase of $6k UGNE by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PRVB | BUY | 2021-12-01 | $25K | — | Filing → |
| PRVB | BUY | 2020-08-18 | $6K | — | Filing → |
| PRVB | BUY | 2020-08-17 | $36K | — | Filing → |